mitoxantrone has been researched along with Pulmonary Fibrosis in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacko, AM | 1 |
| Nan, L | 1 |
| Li, S | 1 |
| Tan, J | 1 |
| Zhao, J | 1 |
| Kass, DJ | 1 |
| Zhao, Y | 1 |
1 other study available for mitoxantrone and Pulmonary Fibrosis
| Article | Year |
|---|---|
De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II.
Topics: Actins; Animals; Bleomycin; Cell Line; Fibroblasts; Fibronectins; Humans; Lung; Mice, Inbred C57BL; | 2016 |